Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7333 p73
22 January 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Access to patient data would improve illness surveillance

Surveillance of winter illnesses and other infections could be greatly enhanced by access to electronic patient data, says a new report.

“A winter’s tale” (PDF 600K), published by the Health Protection Agency last week, outlines the strains put on the health service by the increased levels of infections in winter.

Most surveillance data are currently received from separate sources, the report explains, such as general practitioner-reported cases, hospital admissions and laboratory specimens examined. Combining this data could contribute to the more effective management of these illnesses by the health service.

The report says that the use of a unique identifier such as the NHS number could allow information such as recent antibiotic use, vaccination status and other pathology results to be taken into account in the analysis of surveillance data.

The report acknowledges that the need to maintain patient confidentiality would present a problem for such a system, but says that using unique patient code numbers could overcome this. “At present individuals have the right to bar the use of personal data from being passed to any other person other than those involved in their direct clinical care. Routine surveillance, however, cannot function if patients opt out in this way,” it says.


News feature p76

Back to Top


©The Pharmaceutical Journal